Predict SpAMIL:PRE +2.04%16 EBITDA Margin % is 20.96% as of Dec. 2025, which is 80% above its 10-year median of 11.64. GuruFocus rates MIL:PRE with a GF Score™ of 16/100. The stock has 3 warning signs investors should review. Among 816 Medical Devices & Instruments companies, Predict SpA ranks better than 57.11% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. Predict SpA's EBITDA for the
six
months ended in Dec. 2025 was €1.09 Mil. Predict SpA's Revenue for the
six
months ended in Dec. 2025 was €5.20 Mil. Therefore, Predict SpA's EBITDA margin for the quarter that ended in Dec. 2025 was 20.96%.
Predict SpA (MIL:PRE) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Predict SpA EBITDA Margin % Related Terms
Predict SpA EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Predict SpA's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MIL:PRE vs ABT, SYK, MDT: EBITDA Margin % Comparison
For the Medical Devices subindustry, Predict SpA's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Predict SpA EBITDA Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Predict SpA's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Predict SpA's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Predict SpA (MIL:PRE) has a EBITDA Margin % of 20.96% as of Dec. 2025. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Predict SpA and its competitors. This is 80% above median its historical median of 11.64. Over the past decade, Predict SpA's EBITDA Margin % has ranged from 10.80 to 12.30. According to the industry distribution chart, Predict SpA ranks #350 out of 816 companies in the Medical Devices & Instruments industry, placing it in the top 42.9%.
Is Predict SpA's EBITDA Margin % too high?
Predict SpA's current EBITDA Margin % of 20.96% is 80% above median its 10-year median of 11.64. Over the past 10 years, this metric has ranged from a low of 10.80 to a high of 12.30. The Medical Devices & Instruments industry median EBITDA Margin % is 7.46. Predict SpA's value of 20.96% is 181.2% above this industry median. Based on the distribution chart, Predict SpA ranks #350 out of 816 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Predict SpA has a GF Score™ of 16/100, reflecting its overall financial health beyond just this single metric.
How does Predict SpA's EBITDA Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Predict SpA ranks #350 out of 816 companies for EBITDA Margin %. This puts Predict SpA in the upper half of its industry. The industry median EBITDA Margin % is 7.46. Predict SpA's value of 20.96% is 181.2% above this benchmark. Historically, Predict SpA's own EBITDA Margin % has ranged from 10.80 to 12.30 over the past decade. While the company's 10-year median is 11.64 vs. the industry median of 7.46, Predict SpA has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Medical Devices & Instruments company?
The median EBITDA Margin % among Medical Devices & Instruments companies is 7.46, based on 816 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Predict SpA's current EBITDA Margin % of 20.96% is 181.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Predict SpA and its competitors. For the Medical Devices & Instruments industry, the median EBITDA Margin % is 7.46 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Predict SpA's current EBITDA Margin % is 20.96%, which is 80% above median its own 10-year median of 11.64. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Predict SpA stock overvalued right now?
Predict SpA (MIL:PRE) has a current EBITDA Margin % of 20.96%. The current EBITDA Margin % is 20.96%, which is 80% above median its 10-year median of 11.64 and 181.2% above the Medical Devices & Instruments industry median of 7.46. Predict SpA's overall GF Score™ is 16/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Predict SpA (MIL:PRE), the current EBITDA Margin % is 20.96% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Predict SpA develops innovative healthcare technologies, such as Optip and Mistral, and sells medical diagnostic imaging systems. Its products include Versana Active GE, Optic probe, Versana Balance GE, Voluson S-series, and Vivid T8.
16GF Score
Get the complete analysis for MIL:PRE
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MIL:PRE has been successfully added to your 